These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9886881

  • 1. Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling.
    Ledingham JM, Laverty R.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1945-52. PubMed ID: 9886881
    [Abstract] [Full Text] [Related]

  • 2. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 3. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(1-2):76-85. PubMed ID: 15730439
    [Abstract] [Full Text] [Related]

  • 4. Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):761-3. PubMed ID: 11560124
    [Abstract] [Full Text] [Related]

  • 5. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.
    Ledingham JM, Phelan EL, Cross MA, Laverty R.
    J Vasc Res; 2000 Sep; 37(2):134-45. PubMed ID: 10754398
    [Abstract] [Full Text] [Related]

  • 6. Remodelling of mesenteric arteries in genetically hypertensive rats cross-fostered from birth to normotensive Wistar rats.
    Ledingham JM, Ashton N.
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):859-64. PubMed ID: 16173948
    [Abstract] [Full Text] [Related]

  • 7. Fluvastatin remodels resistance arteries in genetically hypertensive rats, even in the absence of any effect on blood pressure.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):931-4. PubMed ID: 12207574
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of treatment with enalapril on the structure of mesenteric resistance arteries in New Zealand genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S350-2. PubMed ID: 9072424
    [Abstract] [Full Text] [Related]

  • 9. Structure of renal afferent arterioles in the pathogenesis of hypertension.
    Skov K, Mulvany MJ.
    Acta Physiol Scand; 2004 Aug; 181(4):397-405. PubMed ID: 15283751
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):433-5. PubMed ID: 9171951
    [Abstract] [Full Text] [Related]

  • 11. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
    [Abstract] [Full Text] [Related]

  • 12. Effects of losartan and enalapril on small artery structure in hypertensive rats.
    Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ, Agabiti Rosei E.
    Hypertension; 1998 Aug; 32(2):305-10. PubMed ID: 9719059
    [Abstract] [Full Text] [Related]

  • 13. Effects of lisinopril on the structure of renal arterioles.
    Notoya M, Nakamura M, Mizojiri K.
    Hypertension; 1996 Mar; 27(3 Pt 1):364-70. PubMed ID: 8698439
    [Abstract] [Full Text] [Related]

  • 14. Remodelling of resistance arteries by treatment with enalapril in the New Zealand genetically hypertensive rat.
    Ledingham JM, Phelan EL, Cross M, Laverty R, Millar JA.
    Clin Exp Pharmacol Physiol; 1994 Mar; 21(3):235-7. PubMed ID: 8076428
    [Abstract] [Full Text] [Related]

  • 15. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
    Dukacz SA, Kline RL.
    J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
    [Abstract] [Full Text] [Related]

  • 16. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F, Iversen BM, Chatziantoniou C.
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [Abstract] [Full Text] [Related]

  • 17. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
    Nunez E, Hosoya K, Susic D, Frohlich ED.
    Hypertension; 1997 Jan; 29(1 Pt 2):519-24. PubMed ID: 9039153
    [Abstract] [Full Text] [Related]

  • 18. [Regression of vascular remodeling in renovascular hypertensive rats by tetrandrine and enalapril].
    Li QP, Leng J, Peng T, Rao MR.
    Yao Xue Xue Bao; 2003 May; 38(5):328-32. PubMed ID: 12958833
    [Abstract] [Full Text] [Related]

  • 19. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of losartan, enalapril and their combination in the prevention of left ventricular remodeling after acute myocardial infarction in the rat.
    Yuejin Y, Pei Z, Yingmao R, Laifeng S, Xinglin X, Yongli L, Yanwen Z, Yi T, Yishu X, Zaijia C.
    Chin Med Sci J; 2002 Dec; 17(4):236-41. PubMed ID: 12901512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.